REFERENCES
1. Smith, D. S. Reticular organizations within the striated muscle cell: an historical survey of light microscopic studies. J. Biophys. Biochem. Cytol. 10, 61-87 (1961).
3. Atlante, A. ; Valenti, D. Mitochondria have made a long evolutionary path from ancient bacteria immigrants within eukaryotic cells to essential cellular hosts and key players in human health and disease. Curr. Issues Mol. Biol. 45, 4451-79 (2023).
4. Venkatraman, K. ; Lipp, N. F.; Budin, I. Origin and evolution of mitochondrial inner membrane composition. J. Cell Sci. 138, jcs263780 (2025).
5. Cantó, C. Mitochondrial dynamics: shaping metabolic adaptation. Int. Rev. Cell Mol. Biol. (2018) 340, 129-67.
7. El-Hattab, A. W.; Suleiman, J.; Almannai, M.; Scaglia, F. Mitochondrial dynamics: biological roles, molecular machinery, and related diseases. Mol. Genet. Metab. 125, 315-21 (2018).
8. Smith, D. M. The ontogenetic history of the mitochondria of the hepatic cell of the white rat. J. Morphol. 52, 485-511 (1931).
9. Westermann, B. Mitochondrial fusion and fission in cell life and death. Nat. Rev. Mol. Cell Biol. 11, 872-84 (2010).
10. Li, R. ; Toan, S.; Zhou, H. Role of mitochondrial quality control in the pathogenesis of nonalcoholic fatty liver disease. Aging 12, 6467-85 (2020).
11. Bechtel, W. ; Abrahamsen, A. In search of mitochondrial mechanisms: interfield excursions between cell biology and biochemistry. J. Hist. Biol. 40, 1-33 (2007).
12. Pagliarini, D. J.; Rutter, J. Hallmarks of a new era in mitochondrial biochemistry. Genes Dev. 27, 2615-27 (2013).
13. Palade, G. E. An electron microscope study of the mitochondrial structure. J. Histochem. Cytochem. 1, 188-211 (1953).
14. Sjostrand, F. S. Electron microscopy of mitochondria and cytoplasmic double membranes: ultra-structure of rod-shaped mitochondria. Nature 171, 30-2 (1953).
15. Clark-Walker, G. D. Isolation of circular DNA from a mitochondrial fraction from yeast. Proc. Natl. Acad. Sci. U S A. 69, 388-92 (1972).
16. Kummer, E. ; Ban, N. Mechanisms and regulation of protein synthesis in mitochondria. Nat. Rev. Mol. Cell Biol. 22, 307-25 (2021).
17. Nass, M. M.; Nass, S. Intramitochondrial fibers with dna characteristics. I. fixation and electron staining reactions. J Cell Biol. 19, 593-611 (1963).
18. Mitchell, P. Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 191, 144-8 (1961).
19. Mitchell, P. Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biol. Rev. Camb. Philos. Soc. 41, 445-502 (1966).
20. Glater, E. E.; Megeath, L. J.; Stowers, R. S.; Schwarz, T. L. Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent. J. Cell Biol. 173, 545-57 (2006).
21. Guo, X. et al. The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron 47, 379-93 (2005).
22. Liu, X. ; Hajnóczky, G. Ca2+-dependent regulation of mitochondrial dynamics by the Miro-Milton complex. Int. J. Biochem. Cell Biol. 41, 1972-6 (2009).
23. Rice, S. E.; Gelfand, V. I. Paradigm lost: milton connects kinesin heavy chain to miro on mitochondria. J. Cell Biol. 173, 459-61 (2006).
24. Kiezun, M. et al. The effect of estrone and estradiol on the expression of the orexin/hypocretin system in the porcine uterus during early pregnancy. Domest. Anim. Endocrinol. 68, 11-24 (2019).
25. Sheng, Z. H. The interplay of axonal energy homeostasis and mitochondrial trafficking and anchoring. Trends Cell Biol. 27, 403-16 (2017).
26. Du, W. et al. The association between constipation and stroke based on the NHANES and Mendelian randomization study. Front. Neurosci. 17, 1276032 (2023).
27. Zaninello, M. ; Bean, C. Highly specialized mechanisms for mitochondrial transport in neurons: from intracellular mobility to intercellular transfer of mitochondria. Biomolecules 13, 938 (2023).
28. Barnhart, E. L. Mechanics of mitochondrial motility in neurons. Curr. Opin. Cell Biol. 38, 90-9 (2016).
29. Liu, X. ; Kim, C. N.; Yang, J.; Jemmerson, R.; Wang, X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147-57 (1996).
30. Nguyen, T. T. et al. Mitochondria-associated programmed cell death as a therapeutic target for age-related disease. Exp. Mol. Med. 55, 1595-619 (2023).
31. Vakifahmetoglu-Norberg, H. ; Ouchida, A. T.; Norberg, E. The role of mitochondria in metabolism and cell death. Biochem. Biophys. Res. Commun. 482, 426-31 (2017).
32. Jing, F. ; Zhao, M.; Xiong, H.; Zeng, X.; Jiang, J.; Li, T. Mechanisms underlying targeted mitochondrial therapy for programmed cardiac cell death. Front. Physiol. 16, 1548194 (2025).
33. Zhang, Z. ; Zhang, M.; Jin, H.; Lv, S.; Li, Y.; Li, Y. Mitochondrial quality control and cell death. Int. J. Mol. Sci. 26, 11084 (2025).
34. Zhang, J. et al. Mitochondrial orchestration of PANoptosis: mechanisms, disease pathogenesis, and emerging therapeutic frontiers. Cell Death Discov. 11, 476 (2025).
35. Fonseca, T. B.; Sánchez-Guerrero, Á.; Milosevic, I.; Raimundo, N. Mitochondrial fission requires DRP1 but not dynamins. Nature 570, E34-42 (2019).
36. Chen, H. ; Chan, D. C. Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum. Mol. Genet. 18, R169-76 (2009).
37. Wai, T. Is mitochondrial morphology important for cellular physiology? Trends in Endocrinol. Metab. 35, 854-71 (2024).
38. Al Ojaimi, M.; Salah, A.; El-Hattab, A. W. Mitochondrial fission and fusion: molecular mechanisms, biological functions, and related disorders. Membranes 12, 893 (2022).
40. Marsset, M. et al. The Massalia asteroid family as the origin of ordinary L chondrites. Nature 634, 561-5 (2024).
41. Park, J. et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441, 1157-61 (2006).
42. Narendra, D. ; Tanaka, A.; Suen, D. F.; Youle, R. J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183, 795-803 (2008).
43. Narendra, D. P. et al. PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin. PLoS Biol. 8, e1000298 (2010).
44. Kane, L. A. et al. PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J. Cell Biol. 205, 143-53 (2014).
45. Wang, S. et al. The mitophagy pathway and its implications in human diseases. Sig. Transduct. Target. Ther. 8, 304 (2023).
46. Picca, A. ; Faitg, J.; Auwerx, J.; Ferrucci, L.; D’Amico, D. Mitophagy in human health, ageing and disease. Nat. Metab. 5, 2047-61 (2023).
47. Tang, M. ; Outissint, I.; Chen, Y.; Gong, X. Comprehensive insights into mitophagy: mechanisms, disease associations, and therapeutic implications. J. Cell. Biochem. 126, e70056 (2025).
48. Shan, W. ; Liu, Y.; Tang, R.; Li, H.; Yang, H.; Lin, L. Targeting mitochondrial autophagy for anti-aging. Cell Death Discov. 12, 78 (2025).
49. Wang, Q. ; Sun, Y.; Li, T. Y.; Auwerx, J. Mitophagy in the pathogenesis and management of disease. Cell Res. 36, 11-37 (2026).
51. Liu, B. H. et al. Mitochondrial quality control in human health and disease. Mil. Med. Res. 11, 32 (2024).
52. Skawratananond, S. et al. Mitophagy in Alzheimer’s disease and other metabolic disorders: a focus on mitochondrial-targeted therapeutics. Ageing Res. Rev. 108, 102732 (2025).
53. Wang, L. ; Zhou, X.; Lu, T. Role of mitochondria in physiological activities, diseases, and therapy. Mol. Biomed. 6, 42 (2025).
54. Ye, L. ; Fu, X.; Li, Q. Mitochondrial quality control in health and disease. MedComm 6, e70319 (2025).
55. Ying, Z. et al. Transient activation of mitoflashes modulates Nanog at the early phase of somatic cell reprogramming. Cell Metab. 23, 220-6 (2016).
56. Ying, Z. et al. Short-term mitochondrial permeability transition pore opening modulates histone lysine methylation at the early phase of somatic cell reprogramming. Cell Metab. 28, 935-45.e5 (2018).
57. Bhutani, N. ; Brady, J. J.; Damian, M.; Sacco, A.; Corbel, S. Y.; Blau, H. M. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 463, 1042-7 (2009).
58. Prieto, J. et al. Early ERK1/2 activation promotes DRP1-dependent mitochondrial fission necessary for cell reprogramming. Nat. Commun. 7, 11124 (2016).
59. Seo, B. J.; Yoon, S. H.; Do, J. T. Mitochondrial dynamics in stem cells and differentiation. Int. J. Mol. Sci. 19, 3893 (2018).
60. Rasmussen, M. L.; Gama, V. A connection in life and death: the BCL-2 family coordinates mitochondrial network dynamics and stem cell fate. Int. Rev. Cell Mol. Biol. 353, 255-84 (2020).
61. Yildirim, R. M.; Seli, E. The role of mitochondrial dynamics in oocyte and early embryo development. Semin. Cell Dev. Biol. 159-160, 52-61 (2024).
62. Coelho, P. ; Fão, L.; Mota, S.; Rego, A. C. Mitochondrial function and dynamics in neural stem cells and neurogenesis: Implications for neurodegenerative diseases. Ageing Res. Rev. 80, 101667 (2022).
63. Sebastián, D. ; Palacín, M.; Zorzano, A. Mitochondrial dynamics: coupling mitochondrial fitness with healthy aging. Trends Mol. Med. 23, 201-15 (2017).
64. Simula, L. ; Nazio, F.; Campello, S. The mitochondrial dynamics in cancer and immune-surveillance. Semin. Cancer Biol. 47, 29-42 (2017).
65. Kim, S. J.; Ahn, D. G.; Syed, G. H.; Siddiqui, A. The essential role of mitochondrial dynamics in antiviral immunity. Mitochondrion 41, 21-7 (2018).
66. Liao, R. et al. BCL11B and the NuRD complex cooperatively guard T-cell fate and inhibit OPA1-mediated mitochondrial fusion in T cells. EMBO J. 42, e113448 (2023).
67. Wu, Y. et al. Plin2-mediated lipid droplet mobilization accelerates exit from pluripotency by lipidomic remodeling and histone acetylation. Cell Death Differ. 29, 2316-31 (2022).
68. Leutert, M. ; Entwisle, S. W.; Villén, J. Decoding post-translational modification crosstalk with proteomics. Mol. Cell. Proteomics 20, 100129 (2021).
69. Zhong, Q. et al. Protein posttranslational modifications in health and diseases: functions, regulatory mechanisms, and therapeutic implications. MedComm 4, e261 (2023).
70. Guo, H. ; Qian, P. Modulating enzyme activity and specificity by preinstalled posttranslational modifications on substrates: PTM-induced activity stimulation. Biophys. J. 125, 4048-64 (2026).
71. Zhang, S. ; Li, J.; Chen, M.; Huang, H. Post-translational modifications in proteins: prediction methods, biological functions, and diseases. MedComm 7, e70729 (2026).
72. Beltrao, P. ; Bork, P.; Krogan, N. J.; van Noort, V. Evolution and functional cross-talk of protein post-translational modifications. Mol. Syst. Biol. 9, 714 (2013).
73. Xu, D. et al. Blockage of Drp1 phosphorylation at Ser579 protects neurons against Aβ1-42-induced degeneration. Mol. Med. Rep. 24, 657 (2021).
74. Todd, L. R.; Damin, M. N.; Gomathinayagam, R.; Horn, S. R.; Means, A. R.; Sankar, U. Growth factor erv1-like modulates Drp1 to preserve mitochondrial dynamics and function in mouse embryonic stem cells. Mol. Biol. Cell 21, 1225-36 (2010).
75. Wang, X. et al. Impaired balance of mitochondrial fission and fusion in Alzheimer’s disease. J. Neurosci. 29, 9090-103 (2009).
76. Otera, H. et al. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J. Cell Biol. 191, 1141-58 (2010).
77. Yu, R. et al. MIEF1/2 function as adaptors to recruit Drp1 to mitochondria and regulate the association of Drp1 with Mff. Sci. Rep. 7, 880 (2017).
78. Pokhrel, S. et al. A hidden cysteine in Fis1 targeted to prevent excessive mitochondrial fission and dysfunction under oxidative stress. Nat. Commun. 16, 4187 (2025).
79. Rochon, K. et al. Structural basis for regulated assembly of the mitochondrial fission GTPase Drp1. Nat. Commun. 15, 1328 (2024).
80. Egner, J. M. et al. Structural studies of human fission protein FIS1 reveal a dynamic region important for GTPase DRP1 recruitment and mitochondrial fission. J. Biol. Chem. 298, 102620 (2022).
81. Liu, R. ; Chan, D. C. The mitochondrial fission receptor Mff selectively recruits oligomerized Drp1. Mol. Biol. Cell 26, 4466-77 (2015).
82. von der Malsburg, A. et al. Structural mechanism of mitochondrial membrane remodelling by human OPA1. Nature 620, 1101-8 (2023).
83. Nyenhuis, S. B. et al. OPA1 helical structures give perspective to mitochondrial dysfunction. Nature 620, 1109-16 (2023).
84. Cao, Y. L. et al. MFN1 structures reveal nucleotide-triggered dimerization critical for mitochondrial fusion. Nature 542, 372-6 (2017).
85. Li, Y. J. et al. Structural insights of human mitofusin-2 into mitochondrial fusion and CMT2A onset. Nat. Commun. 10, 4914 (2019).
86. Trempe, J. F. et al. Structure of parkin reveals mechanisms for ubiquitin ligase activation. Science 340, 1451-5 (2013).
87. Smith, K. P. et al. Insight into human Miro1/2 domain organization based on the structure of its N-terminal GTPase. J. Struct. Biol. 212, 107656 (2020).
88. Ko, A. R.; Hyun, H. W; Min, S. J.; Kim, J. E. The differential DRP1 phosphorylation and mitochondrial dynamics in the regional specific astroglial death induced by status epilepticus. Front. Cell. Neurosci. 10, 124 (2016).
89. Ferreira, J. C. B. et al. A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats. Nat. Commun. 10, 329 (2019).
90. Martinez, A. et al. c-Abl phosphorylates MFN2 to regulate mitochondrial morphology in cells under endoplasmic reticulum and oxidative stress, impacting cell survival and neurodegeneration. Antioxidants 12, 2007 (2023).
91. Li, J. ; Dang, X.; Franco, A.; Dorn, G. W. Reciprocal regulation of mitofusin 2-mediated mitophagy and mitochondrial fusion by different PINK1 phosphorylation events. Front. Cell Dev. Biol. 10, 868465 (2022).
92. Valera-Alberni, M. et al. Crosstalk between Drp1 phosphorylation sites during mitochondrial remodeling and their impact on metabolic adaptation. Cell Reports 36, 109565 (2021).
93. Han, H. et al. PINK1 phosphorylates Drp1S616 to regulate mitophagy-independent mitochondrial dynamics. EMBO Rep. 21, e48686 (2020).
94. Liu, D. ; Li, J.; Rong, X.; Li, J.; Peng, Y.; Shen, Q. Cdk5 promotes mitochondrial fission via Drp1 phosphorylation at S616 in chronic ethanol exposure-induced cognitive impairment. Mol. Neurobiol. 59, 7075-94 (2022).
95. Hu, S. L. et al. TBK1-medicated DRP1 phosphorylation orchestrates mitochondrial dynamics and autophagy activation in osteoarthritis. Acta Pharmacol. Sin. 44, 610-21 (2023).
96. Yu, Y. et al. Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis. Sig. Transduct. Target. Ther. 6, 401 (2021).
97. Wang, S. et al. DNA-PKcs interacts with and phosphorylates Fis1 to induce mitochondrial fragmentation in tubular cells during acute kidney injury. Sci. Signal. 15, eabh1121 (2022).
98. Meng, Y. et al. Targeting CRL4 suppresses chemoresistant ovarian cancer growth by inducing mitophagy. Sig. Transduct. Target. Ther. 7, 388 (2022).
99. Henschke, S. et al. Food perception promotes phosphorylation of MFFS131 and mitochondrial fragmentation in liver. Science 384, 438-46 (2024).
100. Xiao, J. J. et al. Regulator of calcineurin 1 deletion attenuates mitochondrial dysfunction and apoptosis in acute kidney injury through JNK/Mff signaling pathway. Cell Death Dis. 13, 774 (2022).
101. Pangou, E. et al. A PKD-MFF signaling axis couples mitochondrial fission to mitotic progression. Cell Reports 35, 109129 (2021).
102. Toyama, E. Q. et al. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress. Science 351, 275-81 (2016).
103. Kim, Y. et al. PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochem. Biophys. Res. Commun. 377, 975-80 (2008).
104. Okatsu, K. et al. PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria. Nat. Commun. 3, 1016 (2012).
105. Shiba-Fukushima, K. ; Arano, T. et al. Phosphorylation of mitochondrial polyubiquitin by PINK1 promotes parkin mitochondrial tethering. PLoS Genet. 10, e1004861 (2014).
106. Cherra, S. J. et al. Regulation of the autophagy protein LC3 by phosphorylation. J. Cell Biol. 190, 533-9 (2010).
107. Herhaus, L. et al. TBK1-mediated phosphorylation of LC3C and GABARAP-L2 controls autophagosome shedding by ATG4 protease. EMBO Rep. 21, e48317 (2020).
108. Chen, Y. ; Dorn, G. W. PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science 340, 471-5 (2013).
109. Bhatia, D. et al. Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis. JCI Insight 4, e132826 (2019).
110. Leboucher, G. P. et al. Stress-induced phosphorylation and proteasomal degradation of mitofusin 2 facilitates mitochondrial fragmentation and apoptosis. Mol. Cell 47, 547-57 (2012).
111. Kim, Y. ; Kim, E. K.; Jang, H. H. Fine-tuning protein fate: mechanisms of E1, E2, and E3 enzymes and deubiquitinases in cell signaling. Int. J. Mol. Sci. 27, 3404 (2026).
112. Huang, B. ; Yang, Y.; Liu, J.; Zhang, B.; Lin, N. Ubiquitination regulation of mitochondrial homeostasis: a new sight for the treatment of gastrointestinal tumors. Front. Immunol. 16, 1533007 (2025).
113. Zhang, Z. et al. WTAP-mediated m6A modification of TRIM22 promotes diabetic nephropathy by inducing mitochondrial dysfunction via ubiquitination of OPA1. Redox Rep. 29, 2404794 (2024).
114. Gegg, M. E.; Cooper, J. M.; Chau, K. Y.; Rojo, M.; Schapira, A. H.; Taanman, J. W. Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum. Mol. Genet. 19, 4861-70 (2010).
115. Choi, S. H. et al. Intracellular AIBP (apolipoprotein A-I binding protein) regulates oxidized LDL (low-density lipoprotein)-induced mitophagy in macrophages. Arterioscler. Thromb. Vasc. Biol. 41, e82-96 (2021).
116. Park, Y. Y.; Nguyen, O. T. K.; Kang, H.; Cho, H. MARCH5-mediated quality control on acetylated Mfn1 facilitates mitochondrial homeostasis and cell survival. Cell Death Dis. 5, e1172 (2014).
117. Lee, Y. S. et al. Deficiency of parkin suppresses melanoma tumor development and metastasis through inhibition of MFN2 ubiquitination. Cancer Lett. 433, 156-64 (2018).
118. Liu, Y. et al. Inhibition of USP30 promotes mitophagy by regulating ubiquitination of MFN2 by parkin to attenuate early brain injury after SAH. Transl. Stroke Res. 16, 448-66 (2025).
119. Shen, L. ; Zhang, Q.; Tu, S.; Qin, W. SIRT3 mediates mitofusin 2 ubiquitination and degradation to suppress ischemia reperfusion-induced acute kidney injury. Exp. Cell Res. 408, 112861 (2021).
120. Sugiura, A. et al. MITOL regulates endoplasmic reticulum-mitochondria contacts via Mitofusin2. Mol. Cell 51, 20-34 (2013).
121. Lee, L. ; Seager, R.; Nakamura, Y.; Wilkinson, K. A.; Henley, J. M. Parkin-mediated ubiquitination contributes to the constitutive turnover of mitochondrial fission factor (Mff). PLoS One 14, e0213116 (2019).
122. Cherok, E. et al. Novel regulatory roles of Mff and Drp1 in E3 ubiquitin ligase MARCH5-dependent degradation of MiD49 and Mcl1 and control of mitochondrial dynamics. Mol. Biol. Cell 28, 396-410 (2017).
123. Xiong, H. et al. Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J. Clin. Invest. 119, 650-60 (2009).
124. Spratt, D. E. et al. A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease. Nat. Commun. 4, 1983 (2013).
125. Liu, S. et al. Parkinson’s disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria. PLoS Genet. 8, e1002537 (2012).
126. Xian, H. ; Liou, Y. C. Loss of MIEF1/MiD51 confers susceptibility to BAX-mediated cell death and PINK1-PRKN-dependent mitophagy. Autophagy 15, 2107-25 (2019).
127. Princz, A. ; Pelisch, F.; Tavernarakis, N. SUMO promotes longevity and maintains mitochondrial homeostasis during ageing in Caenorhabditis elegans. Sci. Rep. 10, 15513 (2020).
128. Huang, J. ; Xie, P.; Dong, Y.; An, W. Inhibition of Drp1 SUMOylation by ALR protects the liver from ischemia-reperfusion injury. Cell Death Differ. 28, 1174-92 (2021).
129. Yamada, S. ; Sato, A.; Ishihara, N.; Akiyama, H.; Sakakibara, S. I. Drp1 SUMO/deSUMOylation by Senp5 isoforms influences ER tubulation and mitochondrial dynamics to regulate brain development. iScience 24, 103484 (2021).
130. Zhou, X. et al. Endothelial FIS1 DeSUMOylation protects against hypoxic pulmonary hypertension. Circ. Res. 133, 508-31 (2023).
131. Keller, M. A.; Ivessa, A.; Liu, T.; Li, H.; Romanienko, P. J.; Nakamura, M. KAT6A acetylation drives metabolic adaptation to mediate cellular growth and mitochondrial metabolism through AMPK interaction. bioRxiv (2025) Epub ahead of print.
132. Hu, L. et al. Mfn2/Hsc70 complex mediates the formation of Mitochondria-lipid droplets membrane contact and regulates myocardial lipid metabolism. Adv. Sci. 11, e2307749 (2024).
133. Jin, J. Y.; Wei, X. X.; Zhi, X. L.; Wang, X. H.; Meng, D. Drp1-dependent mitochondrial fission in cardiovascular disease. Acta Pharmacol. Sin. 42, 655-64 (2021).
134. Kalinski, A. L. et al. Deacetylation of Miro1 by HDAC6 blocks mitochondrial transport and mediates axon growth inhibition. J. Cell Biol. 218, 1871-90 (2019).
135. Paik, W. K.; Paik, D. C.; Kim, S. Historical review: the field of protein methylation. Trends Biochem. Sci. 32, 146-52 (2007).
136. Cho, Y. ; Kim, Y. K. ROS-mediated cytoplasmic localization of CARM1 induces mitochondrial fission through DRP1 methylation. Redox Biol. 73, 103212 (2024).
137. Onigbinde, S. et al. Glycomics in human diseases and its emerging role in biomarker discovery. Biomedicines 13, 2034 (2025).
138. Jóźwiak, P. et al. Increased O-GlcNAcylation by upregulation of Mitochondrial O-GlcNAc transferase (mOGT) inhibits the activity of respiratory chain complexes and controls cellular bioenergetics. Cancers 16, 1048 (2024).
139. Akinbiyi, E. O. et al. Blocked O-GlcNAc cycling alters mitochondrial morphology, function, and mass. Sci. Rep. 11, 22106 (2021).
140. Iyer, S. P. N.; Akimoto, Y.; Hart, G. W. Identification and cloning of a novel family of coiled-coil domain proteins that interact with O-GlcNAc transferase. J. Biol. Chem. 278, 5399-409 (2003).
141. Liu, Y. et al. MAVS Cys508 palmitoylation promotes its aggregation on the mitochondrial outer membrane and antiviral innate immunity. Proc. Natl. Acad. Sci. U S A. 121, e2403392121 (2024).
142. Napoli, E. et al. Zdhhc13-dependent Drp1 S-palmitoylation impacts brain bioenergetics, anxiety, coordination and motor skills. Sci. Rep. 7, 12796 (2017).
143. Dong, W. ; Huang, S. X.; Qin, M. L.; Pan, Z. Mitochondrial alanyl-tRNA synthetase 2 mediates histone lactylation to promote ferroptosis in intestinal ischemia-reperfusion injury. World J. Gastrointest. Surg. 17, 106777 (2025).
144. An, S. et al. PDHA1 hyperacetylation-mediated lactate overproduction promotes sepsis-induced acute kidney injury via Fis1 lactylation. Cell Death Dis. 14, 457 (2023).
145. Wang, L. et al. Identification of mitochondrial and succinylation modification-related gene signature in ischemic stroke. Mol. Neurobiol. 62, 11130-44 (2025).
146. Zhu, Y. et al. Carnitine palmitoyltransferase 1A promotes mitochondrial fission by enhancing MFF succinylation in ovarian cancer. Commun. Biol. 6, 618 (2023).
147. Han, F. et al. S-nitrosylation of peroxiredoxin 2 exacerbates hyperuricemia-induced renal injury through regulation of mitochondrial homeostasis. Free Radic. Biol. Med. 230, 66-78 (2025).
148. Cho, D. H. et al. S-Nitrosylation of Drp1 mediates β-amyloid-related mitochondrial fission and neuronal injury. Science 324, 102-5 (2009).
149. Chung, K. K. K. et al. S-nitrosylation of parkin regulates ubiquitination and compromises parkin’s protective function. Science 304, 1328-31 (2004).
150. Sarnataro, R. ; Velasco, C. D.; Monaco, N.; Kempf, A.; Miesenböck, G. Mitochondrial origins of the pressure to sleep. Nature 645, 722-8 (2025).
151. Shen, S. ; Yin, H. E2-Ub-R74G strategy reveals E2-specific ubiquitin conjugation profiles in live cells. Nat. Chem. Biol. 21, 1089-99 (2025).
152. Estévez, M. ; Díaz-Velasco, S.; Martínez, R. Protein carbonylation in food and nutrition: a concise update. Amino Acids 54, 559-73 (2022).
153. Akagawa, M. Protein carbonylation: molecular mechanisms, biological implications, and analytical approaches. Free Radic. Res. 55, 307-20 (2021).
154. Fan, W. et al. The role of protein post-translational modifications and their crosstalk in determining pluripotent stem cells fate. Science Bulletin 70, 3453-6 (2025).
155. Koyano, F. et al. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510, 162-6 (2014).
156. Zhang, S. et al. LRRK2 aggravates kidney injury through promoting MFN2 degradation and abnormal mitochondrial integrity. Redox Biol. 66, 102860 (2023).
157. Guo, T. ; Steen, J. A.; Mann, M. Mass-spectrometry-based proteomics: from single cells to clinical applications. Nature 638, 901-11 (2025).
158. Nelson, J. W. et al. Engineered pegRNAs improve prime editing efficiency. Nat. Biotechnol. 40, 402-10 (2022).
159. Ravitch, E. E. et al. Structural-functional characterization of the MIRO1-TRAK1 complex. Nat. Commun. 16, 6173 (2025).
160. Feng, W. et al. ERK/Drp1-dependent mitochondrial fission contributes to HMGB1-induced autophagy in pulmonary arterial hypertension. Cell Prolif. 54, e13048 (2021).
161. Ko, H. J. et al. The phosphorylation status of Drp1-Ser637 by PKA in mitochondrial fission modulates mitophagy via PINK1/parkin to exert multipolar spindles assembly during mitosis. Biomolecules 11, 424 (2021).
162. Wang, R. et al. SIRT3 promotes metabolic maturation of human iPSC-derived cardiomyocytes via OPA1-controlled mitochondrial dynamics. Free Radic. Biol. Med. 195, 270-82 (2023).
163. Palmer, C. S.; Osellame, L. D.; Laine, D.; Koutsopoulos, O. S.; Frazier, A. E.; Ryan, M. T. MiD49 and MiD51, new components of the mitochondrial fission machinery. EMBO Rep. 12, 565-73 (2011).
164. Ban, T. et al. Molecular basis of selective mitochondrial fusion by heterotypic action between OPA1 and cardiolipin. Nat. Cell Biol. 19, 856-63 (2017).
165. Samant, S. A. et al. SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress. Mol. Cell. Biol. 34, 807-19 (2023).
166. Pyakurel, A. ; Savoia, C.; Hess, D.; Scorrano, L. Extracellular regulated kinase phosphorylates mitofusin 1 to control mitochondrial morphology and apoptosis. Mol. Cell 58, 244-54 (2015).
167. Zhou, J. et al. N6-methyladenosine facilitates mitochondrial fusion of colorectal cancer cells via induction of GSH synthesis and stabilization of OPA1 mRNA. Natl. Sci. Rev. 11, nwae039 (2024).
168. Seager, R. ; Ramesh, N. S.; Cross, S.; Guo, C.; Wilkinson, K. A.; Henley, J. M. SUMOylation of MFF coordinates fission complexes to promote stress-induced mitochondrial fragmentation. Sci. Adv. 10, eadq6223 (2024).
169. Xu, S. et al. Mitochondrial E3 ubiquitin ligase MARCH5 controls mitochondrial fission and cell sensitivity to stress-induced apoptosis through regulation of MiD49 protein. Mol. Biol. Cell 27, 349-59 (2016).
170. Pekkurnaz, G. ; Trinidad, J. C.; Wang, X.; Kong, D.; Schwarz, T. L. Glucose regulates mitochondrial motility via milton modification by O-GlcNAc transferase. Cell 158, 54-68 (2014).
171. Nag, S. ; Szederkenyi, K.; Gorbenko, O.; Tyrrell, H.; Yip, C. M.; Mcquibban, G. A. PGAM5 is an MFN2 phosphatase that plays an essential role in the regulation of mitochondrial dynamics. Cell Rep. 42, 112895 (2023).
172. Zhou, W. et al. Mutation of the protein kinase A phosphorylation site influences the anti-proliferative activity of mitofusin 2. Atherosclerosis 211, 216-23 (2010).
173. Cho, B. et al. CDK5-dependent inhibitory phosphorylation of Drp1 during neuronal maturation. Exp. Mol. Med. 46, e105 (2014).
174. Cereghetti, G. M. et al. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc. Natl. Acad. Sci. U S A. 105, 15803-8 (2008).
175. Serasinghe, M. N. et al. Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors. Mol. Cell 57, 521-36 (2015).
176. Xia, W. et al. Obesity causes mitochondrial fragmentation and dysfunction in white adipocytes due to RalA activation. Nat. Metab. 6, 273-89 (2024).
177. Zhi, M. ; Cao, R.; Fu, X.; Li, L. Mitochondrial fission factor: a living way for mitochondria sensing food. MedComm 5, e770 (2024).
178. Hanada, Y. et al. Alternative splicing of Mff regulates AMPK-mediated phosphorylation, mitochondrial fission and antiviral response. Pharmacol. Res. 209, 107414 (2024).
179. Wang, Z. et al. Pathological roles of ubiquitination and deubiquitination systems in sepsis-induced myocardial dysfunction. Biomol. Biomed. 25, 1444-58 (2025).
180. Yue, W. et al. A small natural molecule promotes mitochondrial fusion through inhibition of the deubiquitinase USP30. Cell Res. 24, 482-96 (2014).
181. Su, D. et al. E3 ubiquitin ligase RBCK1 confers ferroptosis resistance in pancreatic cancer by facilitating MFN2 degradation. Free Radic. Biol. Med. 221, 136-54 (2024).
182. Narendradev, N. D. et al. Endosomal RFFL ubiquitin ligase regulates mitochondrial morphology by targeting mitofusin 2. J. Cell Sci. 138, jcs263830 (2025).
183. Das, P. ; Chakrabarti, O. ISGylation of DRP1 closely balances other post-translational modifications to mediate mitochondrial fission. Cell Death Dis. 15, 184 (2024).
184. Yonashiro, R. et al. A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics. EMBO J. 25, 3618-26 (2006).
185. Zhang, Q. et al. DJ-1 promotes the proteasomal degradation of Fis1: implications of DJ-1 in neuronal protection. Biochem. J. 447, 261-9 (2012).
186. Tilokani, L. et al. Mitochondrial dynamics: overview of molecular mechanisms. Essays Biochem. 62, 341-60 (2018).
187. Lin, Z. et al. The mitochondrial E3 ligase MAPL SUMOylates Drp1 to facilitate mitochondrial fission in intervertebral disc degeneration. Bone Res. 13, 72 (2025).
188. Waters, E. et al. The SUMO protease SENP3 regulates mitochondrial autophagy mediated by Fis1. EMBO Rep. 23, e48754 (2022).
189. Sooyeon, L. ; Go, K. L.; Kim, J. S. Deacetylation of mitofusin-2 by sirtuin-1: a critical event in cell survival after ischemia. Mol. Cell. Oncol. 3, e1087452 (2015).
190. Zhang, J. et al. Drp1 acetylation mediated by CDK5-AMPK-GCN5L1 axis promotes cerebral ischemic injury via facilitating mitochondrial fission. Mol. Med. 30, 173 (2024).
191. Yin, S. ; Dai, D.; Wang, G.; Zhou, S. SIRT1-mediated deacetylation of DRP1 suppresses excessive mitophagy and ameliorates pediatric functional dyspepsia. BMC Immunol. 27, 58 (2026).
192. Xi, Y. et al. SIRT3-mediated deacetylation of DRP1K711 prevents mitochondrial dysfunction in parkinson’s disease. Adv. Sci. 12, 2411235 (2025).
193. Lee, D. S.; Kim, J. E. PDI-mediated S-nitrosylation of DRP1 facilitates DRP1-S616 phosphorylation and mitochondrial fission in CA1 neurons. Cell Death Dis. 9, 869 (2018).
194. Benhar, M. ; Forrester, M. T.; Stamler, J. S. Protein denitrosylation: enzymatic mechanisms and cellular functions. Nat. Rev. Mol. Cell Biol. 10, 721-32 (2009).
195. Aishwarya, R. et al. Pleiotropic effects of mdivi-1 in altering mitochondrial dynamics, respiration, and autophagy in cardiomyocytes. Redox Biol. 36, 101660 (2020).
196. Li, Y. ; Mei, N. H.; Cheng, G. P.; Yang, J.; Zhou, L. Q. Inhibition of DRP1 impedes zygotic genome activation and preimplantation development in mice. Front. Cell Dev. Biol. 9, 788512 (2021).
197. Hao, S. et al. The DRP1 inhibitory peptide P110 provides neuroprotection after subarachnoid hemorrhage by suppressing neuronal apoptosis and stabilizing the blood-brain barrier. Free Radic. Biol. Med. 240, 1-14 (2025).
198. Joshi, A. U.; Saw, N. L.; Vogel, H.; Cunnigham, A. D.; Shamloo, M.; Mochly-Rosen, D. Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis. EMBO Mol. Med. 10, e08166 (2018).
199. Fang, T. Z. et al. Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model. Nat. Commun. 14, 7295 (2023).
200. Cao, C. et al. Deep learning-assisted single-molecule detection of protein post-translational modifications with a biological nanopore. ACS Nano 18, 1504-15 (2024).
